Sridhar Nimmagadda

[Hopkins Med News @HopkinsMedNews]

The new labeling agent could help us monitor differences in checkpoint expression across the body and allow oncologists to compare the performance of different antibody therapies. https://t.co/zc0HYwKDSy 2/3

[Hopkins Med News @HopkinsMedNews]

We show that PD-L1 imaging agents can be used as a common denominator to compare the activity of different antibodies. This will allow us to compare the efficacy of different antibodies early in therapy, identify better drugs and optimize the doses. https://t.co/zc0HYwKDSy 3/3

[Hopkins Med News @HopkinsMedNews]

Collecting biopsies isn't easy for patients who have multiple #Cancers. So, @HopkinsMedicine researchers developed an agent that marks so-called immune checkpoints in the whole body non-invasively for imaging. 1/3
https://t.co/fh7Bd3BSk8

[WMIS WMIC @WMISWMIC]

Congratulations to Jason Lewis, Ph.D. and Martin Pomper, Ph.D.!

Dr. Lewis and Dr. Pomper will receive our highest honor, the Gold Medal Award for Outstanding Contributions to Molecular Imaging at #WMIC2021.

We hope to see you there!

Register here: https://t.co/gi0QZOySvF

[Patrick Forde @FordePatrick]

Nice work by Dr. Sridhar Nimmagadda & colleagues @Imaging4Health We now have an exciting study of a novel PD-L1 PET tracer (developed by Dr. Nimmagadda in his lab at Johns Hopkins) open for pts starting pembrolizumab for lung cancer @HopkinsThoracic @hopkinskimmel #LCSM

[Sridhar Nimmagadda @Imaging4Health]

@HopkinsNucs @michael_gorin Fantastic news! Congratulations @HopkinsNucs

[Sridhar Nimmagadda @Imaging4Health]

@PeterCaravan @harvardmed @MGHImaging @AcadiaU @UBC @MGHMartinos Congratulations @PeterCaravan what a great a way to start a new year!

[Sridhar Nimmagadda @Imaging4Health]

@deniswirtz @JohnsHopkins @HopkinsEngineer @hopkinskimmel @PSOC_JHU @JHU_ChemBE @JHUPath @NCIPhySci @theNCI @theNAEng @theNAMedicine Congratulations @deniswirtz

[Lisa Baird @lisabaird11]

Dr. Martin Pomper Past-President of WMIS delivered a compelling Plenary at ESNM today where he showed his Journey imaging PSMA starting in 1997. He stated PSMA imaging is leading us in the direction of a paradigm shift and a path to cure with imaging.

[Sridhar Nimmagadda @Imaging4Health]

Congratulations Jason! A fantastic recognition to everything that you do.

[@Acadrad @AcadRad]

Congratulations to this week's, and our first, @AcadRad #ImagingInnovator! We are so pleased to announce @LewisLabMSKCC has recently been awarded an @NCIMedia Outstanding Investigator (R35) Award. TY to Dr. Lewis for all of your hard work and your contributions to this community!

[The Nobel Prize @NobelPrize]

The first woman to be awarded a #NobelPrize, the first individual to be awarded two Nobel Prizes and still today the only individual with two Nobel Prizes in two different scientific categories - Marie Skłodowska Curie.

[Sridhar Nimmagadda @Imaging4Health]

@PeterCaravan Thank you Peter.

[Sridhar Nimmagadda @Imaging4Health]

@GElegans1 We are excited to have you, Thank you Assaf.

[Sridhar Nimmagadda @Imaging4Health]

Registration for our workshop @Hopkins_Rad
@HopkinsMedicine "Precision Imaging Agents and Theranostics: Concept to Clinic” is now open!

Emphasis on clinical translation of #PET and #MR imaging agents. Approved for #CME credits.

https://t.co/kfBp1TbJg8

RTs are appreciated.

[The Nobel Prize @NobelPrize]

2019 Medicine Laureates William G. Kaelin Jr, Sir Peter J. Ratcliffe and Gregg L. Semenza have identified molecular machinery that regulates the activity of genes in response to varying levels of oxygen.

#NobelPrize

[Johns Hopkins Kimmel Cancer Center @hopkinskimmel]

Congratulations to Dr Gregg Semenza from @HopkinsMedicine on being awarded the 2019 @NobelPrize in Physiology or Medicine for work focused on how cells detect and respond to oxygen. He shares the honor with Dr William Kaelin and Sir Peter Ratcliffe.

https://t.co/V5l33ZbVNS

[Tim Witney @TimWitney]

Come and join our team! #PhD opportunity on @FindAPhD: We are looking for a talented student interested in understanding how #cancer cells respond to #DNAdamage. We can even visualise this process in vivo! Details here:
https://t.co/Eiu9cjvdbG. Pls get in touch. RTs appreciated

[Sridhar Nimmagadda @Imaging4Health]

Transformative work Mikhail and team. Congratulations!!!

[Mikhail Shapiro (same on bsky) @mikhailshapiro]

Ultrasound imaging of gene expression in mammalian cells. Congratulations @farhadi_arash, Gabrielle Ho, @dannypsawyer, Ray Bourdeau and everyone who helped with this project. Thanks @sciencemagazine for publishing this work and for this highlight: https://t.co/24AHX4kYYC

[NEJM @NEJM]

With a 5-year min follow-up, the combination of nivolumab plus ipilimumab associated with 5-year survival of 52% in patients with metastatic #melanoma, compared with 44% for nivolumab alone and 26% for ipilimumab alone. See the CheckMate 067 trial. #ESMO19 https://t.co/f50KNzH5tp

[Sridhar Nimmagadda @Imaging4Health]

We are thrilled to have @SimonRCherry at @Hopkins_Rad and exited to learn more about @TotalBodyPET project!